{
    "nct_id": "NCT01778946",
    "title": "Nicotinic Treatment of Age-Related Cognitive Decline in Down Syndrome: An Open Label Pilot Trial",
    "status": "COMPLETED",
    "last_update_time": "2022-05-06",
    "description_brief": "This study will ascertain whether nicotine is safe and tolerable in DS patients, help with dose-ranging of nicotine in DS, look for evidence of enhancements in cognitive functioning, and establish evidence for biological and behavioral correlates of nicotinic stimulation effects. The knowledge gained from the translational aspects of this project may also guide the application of new nicotinic drugs in DS and generate, for the first time, data on the importance of nicotinic receptor changes in the development of cognitive impairment in DS adults.\n\nHypotheses:\n\n* Transdermal nicotine treatment will be well tolerated out to one month by non-smoking DS patients without significant adverse effects.\n* Nicotine will enhance cognitive performance by one month compared to baseline and post-treatment testing.\n* Nicotine will enhance functioning detectable by clinician and/or informant ratings (pre-post).",
    "description_detailed": "Over 50% of adults with Down Syndrome (DS) develop Alzheimer's disease (AD) by the age of 60 (Nadel 2003), and life expectancy in DS is now 50-60 years. Thus, age-associated cognitive impairment and dementia in older adults with DS is an urgent public health concern. The investigators propose that nicotinic stimulation is a promising strategy to stabilize or improve cognitive functioning in adults with DS, possibly with additional neuroprotective effects. The investigators have extensive experience investigating the role of nicotinic receptors on human cognition and impairment. This application takes advantage of new insights into treating Mild Cognitive Impairment (MCI-the precursor condition to Alzheimer's Disease (AD) in typically developing individuals) with nicotine to propose an open label pilot study of transdermal nicotine in middle-aged non-smoking DS patients who show early cognitive and/or behavioral changes consistent with MCI/dementia.\n\nThe goal of this study is to establish preliminary evidence for safety, gain preliminary evidence as to whether nicotine enhances cognitive functioning in DS adults, and examine electrophysiological, biological, and behavioral correlates of nicotinic stimulation effects.\n\nThe investigators propose that positive results on cognitive or functional indices that would lead to a larger and longer double-blind trial to test more definitively whether nicotinic stimulation may be cognitively and/or functionally enhancing for DS patients. The knowledge gained from the translational aspects of this project will guide the development of potentially new nicotinic drugs in DS and generate, for the first time, data on the importance of nicotinic receptor changes in the development of cognitive impairment in DS adults. This work also represents the first time that cutting-edge advances in treating MCI/AD in the general population are immediately and rigorously applied to those with DS.",
    "phase": [
        "PHASE1",
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Nicotine",
                    "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg)\n\nModerate Dose Nicotine (14mg)"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "7"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "3"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Nicotine",
                    "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg)\n\nModerate Dose Nicotine (14mg)"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "7"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "40.9",
                                            "spread": "11.9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "BMI",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "Kg/m^2",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "24.9",
                                            "spread": "3.6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Tolerability of Nicotine Intervention",
                    "description": "Maximum transdermal nicotine dosage able to be maintained stably by participants.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "1 Month",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotine",
                            "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg); Moderate Dose Nicotine (14mg)"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "7 mg",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "14 mg",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognitive Improvement - Simple Response Time",
                    "description": "Psychomotor speed was measured by the performance on the CANTAB simple reaction time task",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ms",
                    "timeFrame": "4 time-points over the 6-week testing period: at baseline, day 14, day 28 (end of treatment), and 2-weeks post-treatment on day 42.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotine",
                            "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg); Moderate Dose Nicotine (14mg)"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "760.08",
                                            "spread": "542.96"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "737.13",
                                            "spread": "566.94"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "695.52",
                                            "spread": "344.87"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "772.79",
                                            "spread": "552.51"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Exploratory - Event-Related Potentials",
                    "description": "The investigators will measure daily low-moderate dose nicotine treatment's changes to electrophysiological markers of memory performance using an incidental memory task. The incidental memory task consists of presenting participants with a series of 60 complex images, 50 of which are presented once, and 10 which are repeated 5 times each. The task measures the presence of the late positive potential (LPP), a positive deflection over the parietal cortex which is elevated for the repeated compared to the singly presented images. The presence of this potential is indicative of improved recognition memory.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "\u00b5V",
                    "timeFrame": "4 time-points over the 6-week testing period: at baseline, day 14, day 28 (end of treatment), and 2-weeks post-treatment on day 42.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotine",
                            "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg); Moderate Dose Nicotine (14mg)"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline Repeated",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "7.95",
                                            "spread": "0.78"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14 Repeated",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.64",
                                            "spread": "5.44"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28 Repeated",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.64",
                                            "spread": "4.8"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42 Repeated",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "7.49",
                                            "spread": "3.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Single",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.87",
                                            "spread": "2.03"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14 Single",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.76",
                                            "spread": "2.38"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28 Single",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5.83",
                                            "spread": "3.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42 Single",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5.09",
                                            "spread": "1.33"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognitive Improvement - Continuous Performance Test",
                    "description": "Performance on the Conners' Continuous Performance Test, which is a measure of sustained attention. The main outcome measure was commission errors, which measures attention failures. The commission errors are calculated as T-scores. Higher T-scores indicate worse performance, lower T-scores indicate better performance. Average performance is a score of 50, with a standard deviation of 10.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "T-score",
                    "timeFrame": "4 time-points over the 6-week testing period: at baseline, day 14, day 28 (end of treatment), and 2-weeks post-treatment on day 42.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotine",
                            "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg); Moderate Dose Nicotine (14mg)"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "47.82",
                                            "spread": "11.46"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "49.23",
                                            "spread": "6.41"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "43",
                                            "spread": "7.41"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "42.95",
                                            "spread": "8.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognitive Improvement - Buschke Selective Reminding Task",
                    "description": "Episodic memory performance was assessed by the Buschke Selective Reminding Task. The main outcome metric of this test was the total words correctly recalled.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Words Correctly Recalled",
                    "timeFrame": "4 time-points over the 6-week testing period: at baseline, day 14, day 28 (end of treatment), and 2-weeks post-treatment on day 42.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotine",
                            "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg); Moderate Dose Nicotine (14mg)"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "33.75",
                                            "spread": "24.42"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "41.5",
                                            "spread": "30.97"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "54.5",
                                            "spread": "33.89"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "45.5",
                                            "spread": "32.72"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognitive Improvement - Critical Flicker Fusion Task",
                    "description": "Arousal and vigilance were measured by the Critical Flicker Fusion task. The task used at perceptual performance on ascending and descending frequencies of the task.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Hz",
                    "timeFrame": "4 time-points over the 6-week testing period: at baseline, day 14, day 28 (end of treatment), and 2-weeks post-treatment on day 42.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotine",
                            "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg); Moderate Dose Nicotine (14mg)"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "4"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline Ascending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20.6",
                                            "spread": "8.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14 Ascending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "29.7",
                                            "spread": "8.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28 Ascending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "31.6",
                                            "spread": "8.27"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42 Ascending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "30",
                                            "spread": "11.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Descending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "36.9",
                                            "spread": "9.01"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 14 Descending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "31.3",
                                            "spread": "4.23"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 28 Descending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.3",
                                            "spread": "6.51"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Day 42 Descending Frequency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.2",
                                            "spread": "4.65"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "6-weeks",
            "description": "Adverse events collected through query of subjects about any new or worsening problems or side effects, conducted at each contact.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Nicotine",
                    "description": "Low Dose Nicotine (7mg) Moderate Dose Nicotine (14mg)\n\nAll participants in study will begin with the 7mg patch, titrating from 2 hours/day to a full 16 hours/day over the course of the first 7 days (based on individual tolerance).\n\nDay 7 - Day 28 of the study, participants will apply a new nicotine patch daily. Depending on tolerance, some participants may increase to the moderate dose (14mg) patch.\n\nAll participants will apply a new patch daily for a total of 28 days (1 month)\n\nLow Dose Nicotine (7mg)\n\nModerate Dose Nicotine (14mg)",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 7,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 7,
                    "otherNumAffected": 5,
                    "otherNumAtRisk": 7
                }
            ],
            "otherEvents": [
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 7
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": true
            },
            "pointOfContact": {
                "title": "Dr. Paul Newhouse",
                "organization": "Vanderbilt University Medical Center",
                "email": "paul.newhouse@vanderbilt.edu",
                "phone": "6159360928"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "nicotine (transdermal nicotine patch)"
    ],
    "placebo": [
        "none (open\u2011label pilot trial as titled)"
    ],
    "explanation_target": [
        "Reason: The intervention is nicotine (an alkaloid small molecule that acts on nicotinic acetylcholine receptors) intended to produce cognitive improvements (attention, memory, information processing) and to probe nicotinic receptor effects in Down syndrome adults \u2014 i.e., the trial aims to enhance cognition rather than to target Alzheimer-type pathology (amyloid or tau). \ue200cite\ue202turn0search6\ue202turn0search13\ue201.",
        "Act: Key extracted details from the description \u2014 transdermal nicotine; objectives are safety/tolerability, dose\u2011ranging, evidence of cognitive enhancement, and biological/behavioral correlates of nicotinic stimulation. Prior clinical evidence supports acute and short\u2011term cognitive benefits of transdermal nicotine in Down syndrome and in mild cognitive impairment, which matches the trial\u2019s cognitive\u2011enhancer intent. \ue200cite\ue202turn0search0\ue202turn0search1\ue202turn0search7\ue201.",
        "Reflect: Classification rationale \u2014 per the provided category definitions: this is not a biologic (nicotine is a small molecule), and it does not aim to modify core AD pathology (amyloid/tau), so it is not a disease\u2011targeted biologic or disease\u2011targeted small molecule under those definitions. The primary intended effect is cognitive enhancement (attention/memory/functioning), not primary treatment of neuropsychiatric symptoms. Therefore the correct category is \"cognitive enhancer.\" (Supporting reviews and trials: nicotine/nAChR ligands as cognitive therapeutics; clinical trials showing cognitive effects of transdermal nicotine). \ue200cite\ue202turn0search6\ue202turn0search3\ue202turn0search7\ue201.",
        "Web search results (selected sources used to verify drug identity, mechanism, and cognitive effects): 1) Review on nAChR ligands and cognitive function (nicotine as a cognitive agent). \ue200cite\ue202turn0search6\ue201. 2) PMC randomized pilot showing transdermal nicotine improved attention/memory in MCI (6\u2011month trial). \ue200cite\ue202turn0search7\ue201. 3) Single\u2011dose and small transdermal nicotine studies in Down syndrome reporting cognitive/ERP effects. \ue200cite\ue202turn0search0\ue202turn0search1\ue201. 4) Meta\u2011analysis of transdermal nicotine effects on cognition (attention improvement). \ue200cite\ue202turn0search3\ue201.",
        "Notes/uncertainties: The specific trial title you provided is an open\u2011label pilot (so no placebo control in that study design), which limits inference about effect size versus placebo \u2014 earlier studies in other designs have used placebo patches. I classified based on the described intended effect (cognitive enhancement) and the pharmacology of nicotine; if you would like, I can fetch the exact clinicaltrials.gov record or full protocol for this specific titled study and add direct citations to that registration."
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The trial tests transdermal nicotine \u2014 a small alkaloid that acts as an agonist at neuronal nicotinic acetylcholine receptors (nAChRs) to produce cognitive effects (attention, memory, information processing). The intervention is a neurotransmitter\u2011receptor modulator intended for cognitive enhancement rather than targeting amyloid, tau, inflammation, or other AD core pathologies. \ue200cite\ue202turn0search2\ue202turn0search3\ue202turn0search8\ue201",
        "Act: Extracted details \u2014 drug: nicotine (transdermal nicotine patch); mechanism: activation of nicotinic acetylcholine receptors (nAChRs) to enhance cholinergic neurotransmission and cognition; population: adults with Down syndrome; trial intent: cognitive enhancer (safety/tolerability, dose\u2011ranging, cognitive/biological correlates). Based on these specifics the most appropriate CADRO category is D) Neurotransmitter Receptors. Supporting clinical evidence of cognitive effects of transdermal nicotine in MCI and small DS studies is documented. \ue200cite\ue202turn0search8\ue202turn0search2\ue202turn0search3\ue201",
        "Reflect: The classification as D) Neurotransmitter Receptors fits because the intervention directly targets a neurotransmitter receptor (nAChR) to modulate cognition. It is not aimed at amyloid or tau pathology, nor is it a multi\u2011target biologic or a non\u2011therapeutic diagnostic. Therefore D) is the most specific CADRO match. If the trial had been described only as a generic 'cognitive enhancer' without mechanism, there could be ambiguity; here the mechanism (nicotinic receptor agonism) is explicit, justifying D). \ue200cite\ue202turn0search6\ue202turn0search7\ue201",
        "Web search results (selected sources used): 1) Newhouse et al., Neurology / PMC \u2014 6\u2011month randomized trial of transdermal nicotine in MCI showing improvements in attention/memory and safety (supports nicotine cognitive effects). \ue200cite\ue202turn0search8\ue201 2) Bernert et al. / PubMed \u2014 single\u2011dose transdermal nicotine study in adults with Down syndrome showing ERP/cognitive changes. \ue200cite\ue202turn0search2\ue201 3) Lancet (Effects of transdermal nicotine on cognitive performance in Down's syndrome) \u2014 small placebo\u2011controlled study reporting attention/information\u2011processing improvements. \ue200cite\ue202turn0search6\ue201 4) Springer chapter summarizing single\u2011dose transdermal nicotine in DS (ERP and neuropsychological effects). \ue200cite\ue202turn0search7\ue201"
    ]
}